Masimo (MASI) Asset Writedowns and Impairment (2009 - 2026)
Masimo's (MASI) quarterly Asset Writedowns and Impairment came in at $100000.0 in Q2 2026, down 66.67% year-on-year from $300000.0 in Q2 2025, and down 66.67% quarter-over-quarter from $300000.0 in Q1 2026.
Masimo (MASI) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends
Masimo's Asset Writedowns and Impairment history runs 18 years deep, the most recent figure standing at $100000.0 for Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 66.67% year-over-year to $100000.0 in Q2 2026; TTM through Apr 2026 was $2.8 million, a 6.67% decrease from a year earlier, with the FY2026 full-year figure at $3.0 million, up 150.0% from the prior year.
- Asset Writedowns and Impairment fell to $100000.0 in Q2 2026 per MASI's latest filing, from $300000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $7.0 million in Q3 2023 and bottomed at -$6.4 million in Q4 2023.
- The 5-year median for Asset Writedowns and Impairment is $400000.0 (2022), against an average of $468437.5.
- Across the five-year window, Asset Writedowns and Impairment surged 920.41% in 2022 and slumped 433.33% in 2023, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$1.2 million in 2022, then slumped by 433.33% to -$6.4 million in 2023, then soared by 132.81% to $2.1 million in 2024, then plunged by 52.38% to $1.0 million in 2025, then plunged by 90.0% to $100000.0 in 2026.
- Per Business Quant, the three latest MASI Asset Writedowns and Impairment figures stand at $100000.0 (Q2 2026), $300000.0 (Q1 2026), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 100,000.00 |
| Apr 4, 2026 | 100,000.00 |
| Jan 3, 2026 | 300,000.00 |
| Jan 3, 2026 | 300,000.00 |
| Sep 27, 2025 | 1.00 Mn |
| Sep 27, 2025 | 1.00 Mn |
| Jun 28, 2025 | 1.40 Mn |
| Jun 28, 2025 | 1.40 Mn |
| Mar 29, 2025 | 300,000.00 |
| Mar 29, 2025 | 300,000.00 |
| Dec 28, 2024 | 2.10 Mn |
| Dec 28, 2024 | 2.10 Mn |
| Jun 29, 2024 | 600,000.00 |
| Jun 29, 2024 | 600,000.00 |
| Mar 30, 2024 | 100,000.00 |
| Mar 30, 2024 | 100,000.00 |
| Dec 30, 2023 | -6.40 Mn |
| Dec 30, 2023 | -6.40 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Sep 30, 2023 | 7.00 Mn |